US › Healthcare

Haleon plc (HLN)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$9.78-0.20%

Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue

$5.52B

Revenue YoY

+98.4%

Net profit

$855.7M

Profit YoY

+76.4%

EPS

$0.00

EPS estimate

$0.12

Net margin

15.5%

EPS came in at 0.00 against a street estimate of 0.12 — a miss of 100.0%.

Key statistics

Market cap

$43.16B

P/E

20.4

Forward P/E

18.5

P/B

1.99

Book value

$4.97

EPS (TTM)

$0.48

Dividend yield

1.96%

52-week high

$11.13

52-week low

$8.60

50-day MA

$9.43

200-day MA

$9.78

Beta

0.24

Analyst view

Analysts rate Haleon plc a buy (4 buy, 0 hold, 1 sell out of 5) with an average price target of $11.75.

Shareholding

Insiders

0.01%

Institutions

13.26%

Largest institutional holders

Fund	Stake
Dodge & Cox	3.33%
FMR Inc	2.59%
ClearBridge Advisors, LLC	0.72%
Morgan Stanley - Brokerage Accounts	0.44%
Harding Loevner L.P.	0.36%
Harris Associates L.P.	0.34%
Arrowstreet Capital Limited Partnership	0.33%
Bank of America Corp	0.25%

Corporate actions

Action	Detail	Date
Dividend	$0.06 / share ex-date Aug 14, 2026 · pay Sep 17, 2026	2026-08-14
Dividend	$0.13 / share ex-date Apr 10, 2026 · pay May 14, 2026	2026-04-10
Dividend	$0.06 / share ex-date Aug 15, 2025 · pay Sep 18, 2025	2025-08-15

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Haleon plc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.